PMCK BhdXKLS:0363 15 EBITDA Margin % is 23.97% as of Apr. 2026, which is 4% above its 10-year median of 23.05. GuruFocus rates XKLS:0363 with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 664 Healthcare Providers & Services companies, PMCK Bhd ranks better than 84.64% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. PMCK Bhd's EBITDA for the
three
months ended in Apr. 2026 was RM4.56 Mil. PMCK Bhd's Revenue for the
three
months ended in Apr. 2026 was RM19.02 Mil. Therefore, PMCK Bhd's EBITDA margin for the quarter that ended in Apr. 2026 was 23.97%.
PMCK Bhd (XKLS:0363) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
PMCK Bhd EBITDA Margin % Related Terms
PMCK Bhd EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for PMCK Bhd's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0363 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, PMCK Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMCK Bhd EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PMCK Bhd's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where PMCK Bhd's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMCK Bhd (XKLS:0363) has a EBITDA Margin % of 23.97% as of Apr. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PMCK Bhd and its competitors. This is near median its historical median of 23.05. Over the past decade, PMCK Bhd's EBITDA Margin % has ranged from 20.62 to 25.89. According to the industry distribution chart, PMCK Bhd ranks #102 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 15.4%.
Is PMCK Bhd's EBITDA Margin % too high?
PMCK Bhd's current EBITDA Margin % of 23.97% is near median its 10-year median of 23.05. Over the past 10 years, this metric has ranged from a low of 20.62 to a high of 25.89. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. PMCK Bhd's value of 23.97% is 134.8% above this industry median. Based on the distribution chart, PMCK Bhd ranks #102 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PMCK Bhd has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does PMCK Bhd's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PMCK Bhd ranks #102 out of 664 companies for EBITDA Margin %. This places PMCK Bhd in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. PMCK Bhd's value of 23.97% is 134.8% above this benchmark. Historically, PMCK Bhd's own EBITDA Margin % has ranged from 20.62 to 25.89 over the past decade. While the company's 10-year median is 23.05 vs. the industry median of 10.21, PMCK Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PMCK Bhd's current EBITDA Margin % of 23.97% is 134.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PMCK Bhd and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMCK Bhd's current EBITDA Margin % is 23.97%, which is near median its own 10-year median of 23.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMCK Bhd stock overvalued right now?
PMCK Bhd (XKLS:0363) has a current EBITDA Margin % of 23.97%. The current EBITDA Margin % is 23.97%, which is near median its 10-year median of 23.05 and 134.8% above the Healthcare Providers & Services industry median of 10.21. PMCK Bhd's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PMCK Bhd (XKLS:0363), the current EBITDA Margin % is 23.97% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMCK Bhd is a healthcare service provider in Malaysia operating through its Putra Medical Centre. The company focuses on specialist consultant services across various medical fields such as anaesthesiology, cardiology, dermatology, emergency medicine, internal medicine, ophthalmology, orthopaedics, paediatrics, radiology, and surgery among others. Also, it provides healthcare support services including facility management, ward services, clinical support, medication sales, and nursing care, as well as general dental, polyclinic, and medical laboratory services. PMCK generates revenue majorly from these healthcare services and has a broad panel coverage with multiple insurance companies and government agencies facilitating patient access.
15GF Score
Get the complete analysis for XKLS:0363
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0363 has been successfully added to your 
